Hong Kong Stock Movement | CLOUDR (09955) Surges Over 4% in Morning Session as Company's Generative Medical AI Large Model Research Project Selected for Hangzhou Key Scientific Research Plan

Stock News
Aug 01

CLOUDR (09955) surged over 4% in morning trading. As of press time, the stock was up 4.03% to HK$1.55, with a turnover of HK$3.1421 million.

On the news front, Hangzhou Science and Technology Bureau recently officially announced the list of approved projects for the "2025 Municipal Key Scientific Research Plan." CLOUDR's (Hangzhou Kangsheng Health Management Consulting Co., Ltd.) project titled "Construction of Generative Medical AI Large Model and Key Technology Research for Remote Decision Support" successfully made the list, once again demonstrating the company's strong capabilities in the medical AI field.

Currently, the medical AI large model has been piloted in multiple hospitals nationwide, with plans to further expand coverage and application depth to benefit more medical institutions and patients.

According to reports, CLOUDR's generative medical AI large model is based on a medical information transmission system utilizing IoT sensing technology and precise data routing algorithms. Through multimodal sensing devices, it conducts dynamic data collection of health parameters for chronic disease patients in typical clinical scenarios, establishing encrypted transmission channels and data cleaning mechanisms for telemedicine.

The company has also developed an intelligent diagnostic assistance system with parameter self-optimization capabilities. Through deep reinforcement learning, it achieves real-time dynamic tuning of decision model parameters, focusing on improving the accuracy and timeliness of remote diagnosis for clinical scenarios including diabetes, cardiovascular diseases, and chronic obstructive pulmonary disease. This creates a comprehensive closed-loop medical assistance system covering "data collection - secure transmission - intelligent decision-making."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10